US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SS Innovations International, Inc.

7.18

-0.0200-0.28%

Post-market: 7.180.00000.00%18:25 EDT

Volume:40.31K

Turnover:289.55K

Market Cap:1.39B

PE:-82.80

High:7.79

Open:6.95

Low:6.95

Close:7.20

Loading ...

Overview Company News Filings

SS Innovations Reports First Intercontinental Remote Cardiac Surgery

MT Newswires Live

SS Innovations International Inc. Receives Regulatory Approval from India's CDSCO for Revolutionary Telesurgery and Tele Proctoring Capabilities

SS Innovations International Inc. to Submit De Novo Application for SSi Mantra FDA Approval by July 2025

SS Innovations Says SSi Mantra 3 System Used in Robotic Telesurgery for Weight Loss

MT Newswires Live

Top Premarket Decliners

MT Newswires Live

SS Innovations Completes Robotic Cardiac Surgery Using SSi Mantra 3 System

MT Newswires Live

Ss Innovations International Inc - EU Ce Mark Decision Expected Late 2025, FDA Decision in 2026

THOMSON REUTERS

SS Innovations International Inc. Appoints Dr. Vishwajyoti P. Srivastava as CEO - Asia Pacific with Increased Compensation

SS Innovations International Inc. Files Initial Beneficial Ownership Statement for Interim CFO Arvind Palaniappan

SS Innovations Q1 EPS $(0.03), Sales $5.10M

SS Innovations Reports 40.8% Revenue Increase in Q1 2025, Net Loss Narrows to $5.7 Million, EPS at $(0.03)

BRIEF-SS Innovations Reports First Quarter 2025 Financial Results

Ss Innovations Reports First Quarter 2025 Financial Results

THOMSON REUTERS

Ss Innovations International Inc - Qtrly Revenue Increased 40.8% to $5.1 Mln

THOMSON REUTERS

Ss Innovations International Inc - on Track for July 2025 De Novo Application to FDA for Ssi Mantra 3

THOMSON REUTERS

Ss Innovations to Submit De Novo Application to the FDA for the Ssi Mantra 3 Surgical Robotic System for Multiple Indications

THOMSON REUTERS

Ss Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

THOMSON REUTERS

Press Release: SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

BRIEF-SS Innovations Announces CFO Transition

SS Innovations International Names Arvind Palaniappan Interim CFO

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SSII/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSII","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSII\",,,,,undefined,":{"symbol":"SSII","market":"US","secType":"STK","nameCN":"SS Innovations International, Inc.","latestPrice":7.18,"timestamp":1753473600000,"preClose":7.2,"halted":0,"volume":40311,"hourTrading":{"tag":"盘后","latestPrice":7.18,"preClose":7.18,"latestTime":"18:25 EDT","volume":104,"amount":745.46,"timestamp":1753482352332},"delay":0,"floatShares":31516267,"shares":193603970,"eps":-0.086715,"marketStatus":"Closed","change":-0.02,"latestTime":"07-25 16:00:00 EDT","open":6.95,"high":7.7932,"low":6.95,"amount":289551.145111,"amplitude":0.117111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.086715,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":7.2,"preHourTrading":{"tag":"盘前","latestPrice":7.09,"preClose":7.2,"latestTime":"09:28 EDT","volume":93,"amount":659.5100115,"timestamp":1753450080079},"postHourTrading":{"tag":"盘后","latestPrice":7.18,"preClose":7.18,"latestTime":"18:25 EDT","volume":104,"amount":745.46,"timestamp":1753482352332},"volumeRatio":0.326207},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SSII\",,,,,undefined,":{"symbol":"SSII","floatShares":31516267,"roa":"-19.93%","roe":"-55.43%","lyrEps":-0.112095,"volumeRatio":0.326207,"shares":193603970,"dividePrice":0,"high":7.7932,"amplitude":0.117111,"preClose":7.2,"low":6.95,"week52Low":0.32,"pbRate":"34.28","psRate":"62.81","week52High":22.42,"institutionHeld":0,"latestPrice":7.18,"eps":-0.086715,"divideRate":0,"volume":40311,"delay":0,"ttmEps":-0.086715,"open":6.95,"prevYearClose":7.89,"prevWeekClose":7.93,"prevMonthClose":5.89,"prevQuarterClose":5.89,"fiveDayClose":7.93,"twentyDayClose":6.54,"sixtyDayClose":10.68},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSII\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553425674","title":"SS Innovations Reports First Intercontinental Remote Cardiac Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2553425674","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553425674?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:22","pubTimestamp":1753190574,"startTime":"0","endTime":"0","summary":"SS Innovations International  said Tuesday that its chief executive officer, Sudhir Srivastava, performed what the company called the first intercontinental remote robotic cardiac surgery with its SSi Mantra 3 system.The operation, carried out on Saturday, involved a surgeon in France remotely operating on a patient in India and was completed without reported technical issues, the company said.The surgery was supported by local medical personnel at the patient site in Indore and monitored during a robotic surgery conference, the company said.Shares of the company were up more than 2% in recent Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2553255277","title":"SS Innovations International Inc. Receives Regulatory Approval from India's CDSCO for Revolutionary Telesurgery and Tele Proctoring Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2553255277","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553255277?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:46","pubTimestamp":1753188395,"startTime":"0","endTime":"0","summary":"SS Innovations International Inc. Receives Regulatory Approval from India's CDSCO for Revolutionary Telesurgery and Tele Proctoring Capabilities. SS Innovations International Inc. has achieved a significant milestone by receiving regulatory approval from the Central Drugs Standard Control Organization , India's equivalent of the U.S. Food and Drug Administration, for both tele proctoring and telesurgery. This approval is pivotal for the company's advanced SSi Mantra surgical robotic technology platform, which includes cutting-edge telesurgery capabilities. The approval further enables SS Innovations to advance its mission of making robotic surgery affordable and accessible globally while addressing traditional obstacles related to travel, time, cost, and surgical accessibility.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL9Kmrlw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2551162790","title":"SS Innovations International Inc. to Submit De Novo Application for SSi Mantra FDA Approval by July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2551162790","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551162790?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:46","pubTimestamp":1752583572,"startTime":"0","endTime":"0","summary":"SS Innovations International Inc. has announced its intention to submit a De Novo application for regulatory approval to market the SSi Mantra Surgical Robotic System to the U.S. Food and Drug Administration by the end of July 2025. This move is part of the company's efforts to expand its reach and make robotic surgery more accessible globally. Concurrently, SS Innovations is also pursuing a European Union CE marking certification, which they aim to obtain as soon as late 2025. These regulatory endeavors reflect the company's commitment to democratizing access to advanced surgical technologies and expanding its market presence beyond its current installations in India and six other countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL7MLG59:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2550862308","title":"SS Innovations Says SSi Mantra 3 System Used in Robotic Telesurgery for Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2550862308","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550862308?lang=en_us&edition=fundamental","pubTime":"2025-07-10 21:21","pubTimestamp":1752153681,"startTime":"0","endTime":"0","summary":"SS Innovations International  said Thursday its SSi Mantra 3 surgical robotic system was used in robotic telesurgery for weight loss.Two procedures were remotely performed, with zero perceptible lag, by bariatric surgeon Mohit Bhandari from Gurugram, India, while the patient and support team were located about 560 miles away at a healthcare facility in Indore, SS Innovations said.Shares of the company were up more than 6% in recent premarket activity Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2545541935","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2545541935","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545541935?lang=en_us&edition=fundamental","pubTime":"2025-06-23 19:44","pubTimestamp":1750679096,"startTime":"0","endTime":"0","summary":"Next Technology Holding (NXTT) shares were down 31% pre-bell Monday, paring Friday's rally.SS Innovations International (SSII) stock was 18% lower, shaving gains from the previous session.Regencell Bioscience Holdings (RGC) shares were down 14%, extending Friday's slide.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NXTT","BK4023","BK4082","BK4007","SSII","BK4539"],"gpt_icon":0},{"id":"2543033806","title":"SS Innovations Completes Robotic Cardiac Surgery Using SSi Mantra 3 System","url":"https://stock-news.laohu8.com/highlight/detail?id=2543033806","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543033806?lang=en_us&edition=fundamental","pubTime":"2025-06-16 21:50","pubTimestamp":1750081822,"startTime":"0","endTime":"0","summary":"SS Innovations International  said Monday that its SSi Mantra 3 surgical robotic system was used successfully to perform robotic cardiac surgery.The company said the surgery involved a robotic Atrial Septal Defect closure, which is a procedure that repairs a hole between the two upper chambers of the heart.SS Innovations also said it was the first time the robotic system had been used in the Americas and Western Hemisphere.Shares of the company were up 5% in recent trading.Price: 3.70, Change: +0.16, Percent Change: +4.52","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2538469864","title":"Ss Innovations International Inc - EU Ce Mark Decision Expected Late 2025, FDA Decision in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2538469864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538469864?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:35","pubTimestamp":1748349304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RZ1H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2537478131","title":"SS Innovations International Inc. Appoints Dr. Vishwajyoti P. Srivastava as CEO - Asia Pacific with Increased Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=2537478131","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537478131?lang=en_us&edition=fundamental","pubTime":"2025-05-23 21:08","pubTimestamp":1748005734,"startTime":"0","endTime":"0","summary":"SS Innovations International Inc. has announced a key management change with the appointment of Dr. Vishwajyoti P. Srivastava as the Chief Executive Officer for the Asia Pacific region. Previously serving as the President and Chief Operating Officer - Asia, Dr. Srivastava will now oversee all aspects of the company's operations in the region, including departmental oversight, marketing, regulatory affairs, and business expansion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely resp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL709f5w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SSII"],"gpt_icon":0},{"id":"2536637628","title":"SS Innovations International Inc. Files Initial Beneficial Ownership Statement for Interim CFO Arvind Palaniappan","url":"https://stock-news.laohu8.com/highlight/detail?id=2536637628","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536637628?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:06","pubTimestamp":1747685178,"startTime":"0","endTime":"0","summary":"SS Innovations International Inc. has filed an initial statement of beneficial ownership. The filing lists Arvind Palaniappan as the beneficial owner, serving in the role of Interim CFO. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL8cZs9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2535888523","title":"SS Innovations Q1 EPS $(0.03), Sales $5.10M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535888523","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535888523?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:49","pubTimestamp":1747255741,"startTime":"0","endTime":"0","summary":"SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.03) per share.  The company reported $5.10 million in sales this quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45422223/ss-innovations-q1-eps-0-03-sales-5-10m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII"],"gpt_icon":0},{"id":"2535379888","title":"SS Innovations Reports 40.8% Revenue Increase in Q1 2025, Net Loss Narrows to $5.7 Million, EPS at $(0.03)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535379888","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535379888?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:45","pubTimestamp":1747255510,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL2zrsgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII"],"gpt_icon":0},{"id":"2535192000","title":"BRIEF-SS Innovations Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535192000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535192000?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:35","pubTimestamp":1747254927,"startTime":"0","endTime":"0","summary":"BRIEF-SS Innovations Reports First Quarter 2025 Financial ResultsMay 14 (Reuters) - SS Innovations International Inc SSII.O:SS INNOVATIONS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTSSS INNOVATIONS IN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA8BXWS1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SSII"],"gpt_icon":0},{"id":"2535100066","title":"Ss Innovations Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535100066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535100066?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:32","pubTimestamp":1747254763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA8BXWS1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SSII"],"gpt_icon":0},{"id":"2535000664","title":"Ss Innovations International Inc - Qtrly Revenue Increased 40.8% to $5.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2535000664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535000664?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:32","pubTimestamp":1747254763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA8BXWS1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SSII"],"gpt_icon":0},{"id":"2535000061","title":"Ss Innovations International Inc - on Track for July 2025 De Novo Application to FDA for Ssi Mantra 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2535000061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535000061?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:32","pubTimestamp":1747254763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA8BXWS1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2533020138","title":"Ss Innovations to Submit De Novo Application to the FDA for the Ssi Mantra 3 Surgical Robotic System for Multiple Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2533020138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533020138?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:19","pubTimestamp":1746710346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nTUA9MNN5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2533589933","title":"Ss Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589933?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA5YNHNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SSII"],"gpt_icon":0},{"id":"2533589646","title":"Press Release: SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589646","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589646?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448200,"startTime":"0","endTime":"0","summary":"SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends. FORT LAUDERDALE, Fla., May 05, 2025  -- SS Innovations International, Inc.  , a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025.Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, \"Following our recent uplisting to Nasdaq, we remain very pleased with the growth trajectory of our business as we conclude the first quarter of 2025 and enter the second quarter. We believe that we are well-positioned to maintain this momentum and achieve new and impactful milestones throughout 2025.\". -- 14 SSi Mantra surgical robotic systems were installed during the first. $6.4 million with a gross margin of approximately 45%, based on. The SSi Mantra Surgical Robotic System is a user-friendly","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","SSII","BK4082"],"gpt_icon":0},{"id":"2532021849","title":"BRIEF-SS Innovations Announces CFO Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2532021849","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532021849?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:24","pubTimestamp":1746192286,"startTime":"0","endTime":"0","summary":"BRIEF-SS Innovations Announces CFO TransitionMay 2 (Reuters) - SS Innovations International Inc SSII.O:SS INNOVATIONS ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITIONSS INNOVATIONS INTERNATIONAL INC - APP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nTUA9HN78C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSII","BK4082"],"gpt_icon":0},{"id":"2532849478","title":"SS Innovations International Names Arvind Palaniappan Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2532849478","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532849478?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:18","pubTimestamp":1746191886,"startTime":"0","endTime":"0","summary":"SS Innovations International (SSII) said Friday it has named Arvind Palaniappan interim chief financial officer, which was effective Thursday.Palaniappan succeeds CFO Anup Sethi, who the company said ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","SSII"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSII\",params:#limit:5,,,undefined,":[{"date":"2025-05-14","symbol":"SSII","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1747252800000,"name":null,"time":"Post Market","dateTimestamp":1747195200000,"actualEps":null},{"market":"US","date":"2025-04-25","symbol":"SSII","reason":null,"defaultRemindTime":1745587800000,"announcedDate":"2025-04-24","type":"delisting","dateTimestamp":1745553600000},{"market":"US","date":"2025-04-15","symbol":"SSII","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSII\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSII\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SSII\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SSII","date":"2025-07-24","current":-88.466757,"percent":0.42623,"low":-128.473185,"twenty":-108.376176,"median":-81.303138,"eighty":-66.098228,"high":-41.84413,"avg":-85.556296,"sd":22.284291,"marketCap":1326187194},"quantilePoints":[{"date":"2025-04-25","current":-80.855245,"twenty":-85.706559,"median":-83.887316,"eighty":-82.068074,"marketCap":1548474720},{"date":"2025-05-02","current":-109.205115,"twenty":-109.862064,"median":-108.573433,"eighty":-86.919388,"marketCap":2091408668},{"date":"2025-05-09","current":-102.382954,"twenty":-109.205115,"median":-106.223578,"eighty":-102.382954,"marketCap":1960756114},{"date":"2025-05-16","current":-128.473185,"twenty":-109.205115,"median":-103.090437,"eighty":-101.978677,"marketCap":1925915433},{"date":"2025-05-23","current":-116.206901,"twenty":-115.819544,"median":-107.941752,"eighty":-102.382954,"marketCap":1742034060},{"date":"2025-05-30","current":-77.876576,"twenty":-115.199774,"median":-106.223578,"eighty":-99.546956,"marketCap":1167431939},{"date":"2025-06-06","current":-77.48913,"twenty":-114.136183,"median":-102.585092,"eighty":-80.259511,"marketCap":1161623820},{"date":"2025-06-13","current":-50.367935,"twenty":-110.833166,"median":-102.382954,"eighty":-76.63675,"marketCap":755055483},{"date":"2025-06-20","current":-63.024492,"twenty":-109.942919,"median":-101.574401,"eighty":-64.574275,"marketCap":944787373},{"date":"2025-06-27","current":-84.463152,"twenty":-109.467895,"median":-88.145093,"eighty":-70.024344,"marketCap":1266169963},{"date":"2025-07-03","current":-68.965326,"twenty":-108.982763,"median":-83.107092,"eighty":-70.566768,"marketCap":1033845199},{"date":"2025-07-11","current":-69.223623,"twenty":-108.366242,"median":-77.876576,"eighty":-66.588992,"marketCap":1037717279},{"date":"2025-07-18","current":-107.451594,"twenty":-107.745689,"median":-77.682853,"eighty":-64.910061,"marketCap":1610785030},{"date":"2025-07-24","current":-88.466757,"twenty":-108.376176,"median":-81.303138,"eighty":-66.098228,"marketCap":1326187194}],"updateTime":1753491052352}}}